CAR T: New form of immunotherapy – KSAT San Antonio
KSAT San Antonio |
CAR T: New form of immunotherapy
KSAT San Antonio TAMPA, Fla. (Ivanhoe Newswire) – A new form of immunotherapy is being called a milestone in cancer treatment. Could this be the big break patients have been waiting for? Jeffrey Backer didn’t think he’d be taking a swing ever again. |
News 10NBC |
New drug help patients battle cancer through immunotherapy
News 10NBC This is Kidney Cancer Awareness Month and in memory of News10NBC’s longtime anchor/reporter Gabe Dalmath, we are reporting on an encouraging new drug being used to treat the disease that killed him in 2006. It’s called Nivolumab and is a drug that’s … |
Turn to 10 |
Health Check: Stem cell treatment for ALS
Turn to 10 The couple, who are raising an active 7-month-old, Arthur Jr., decided that wasn’t good enough. They learned about stem cell treatments. But finding a trial to sign up for was quite the job. This Rhode Island couple went to Massachusetts and Connecticut. |
Turn to 10 |
Health Check: Stem cell treatment for ALS
Turn to 10 The couple, who are raising an active 7-month-old, Arthur Jr., decided that wasn’t good enough. They learned about stem cell treatments. But finding a trial to sign up for was quite the job. This Rhode Island couple went to Massachusetts and Connecticut. |
UCLA Newsroom |
Pioneering stem cell gene therapy cures infants with bubble baby disease
UCLA Newsroom UCLA researchers have developed a stem cell gene therapy cure for babies born with adenosine deaminase-deficient severe combined immunodeficiency, a rare and life-threatening condition that can be fatal within the first year of life if left untreated. Study points to dangers in unproven stem cell treatments in local clinicsMiami’s Community Newspapers 12th Annual Wisconsin Stem Cell SymposiumYahoo Finance What’s Next For US Stem Cell Inc (OTCMKTS:USRM)?Insider Financial GenomeWeb –News-Medical.net –Technology Networks all 23 news articles » |
Northwest Herald |
Gene therapy to fight a blood cancer succeeds
Northwest Herald Its sponsor, California-based Kite Pharma, is racing Novartis AG to become the first to win approval of the treatment, called CAR-T cell therapy, in the U.S. It could become the nation’s first approved gene therapy. A hopeful sign: the number in … |
